MIFAMED ApS: Financial statements 2013
CVR: 71169413
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MIFAMED ApS (CVR 71169413) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 78,702 and a net result of DKK -148,676. Equity in the 2013 report amounted to DKK 2,370,206. The solvency ratio was 81.5%.
- Gross Profit
- DKK 78,702
- Profit/Loss
- DKK -148,676
- Equity
- DKK 2,370,206
- Total Assets
- DKK 2,909,841
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MIFAMED ApS has published its interim report for the period May 1, 2012 – December 31, 2012.
As of March 15, 2013, Kim Erik Ginnerup is registered as adm. dir of MIFAMED ApS.
As of March 15, 2013, Mikkel Mørkedal Wakefield has stepped down as adm. dir of MIFAMED ApS.
About MIFAMED ApS
MIFAMED ApS was a Danish company of the type Anpartsselskab based in Lynge, founded in 1982. The company has been dissolved on 30 December 2020. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named MIPHAMED ApS and GK-PHARMA ALLERØD ApS. The company has 0 employees (2000). In 2020, the company reported a net result of DKK -21,255 compared with DKK -20,364 the year before. Equity in the 2020 report amounted to DKK 2,310,027.